Preticks
.
Follow Us
News Details
InflaRx Announces Decision to Enter Phase III Development of IFX-1 in Severe COVID-19 Induced Pneumonia
About InflaRx N.V.
NASDAQ: $IFRX
Notified: $6.12
07:30 EDT
Price Chart